2024 Key Milestones in Research: Phase II funding from the National Institute of Aging, partnership with Dr. Anil Rama at the Sleep and Brain Clinic, Menlo Park, CA, groundbreaking trials with Dr. Allison Waters at Mount Sinai, AdvaMed Device of the Week for the Sleep WISP, constant presence in Podcasts and Science Talks, impactful showcases at SLEEP 2024, and successful crowdfunding raise with RedCrow and Alira Health.
Thank you for joining us on this journey!

NATO: "HUMAN DIGITAL TWIN IN THE MILITARY: Findings and Perspective." During this conference Dec. 10-12 in Orlando, Florida, BEL and Neurosom Chief Scientist Dr. Phan Luu will present a paper titled, "Electrocortical Neuromorphic Augmented Cognition Transmission (ENACT) for Human Digital Twin Communication". Dr. Luu will propose a new technology (ENACT) that draws on current HD EEG and Individual Head Model brain mapping, Machine Learning sleep staging classification, Transcranial Electrical Stimulation (TES), and current and future AI digital twin technologies to provide augmented cognitive human performance during military operations.

Neurosom's Chief Science Officer, Dr. Phan Luu, PhD, will present a talk "Transcranial Electrical Stimulation (TES) targeting limbic cortex increases the duration of human deep sleep" at the UK Royal Society Meeting in London on November 26th (10:30-10:50 am ET). Dr. Luu's talk will present evidence that slow-wave sleep can be enhanced through Neurosom Sleep Therapy, a portable, user-friendly device deployed in the home. The ability to selectively enhance slow-wave sleep has significant implications for health. The lecture is free to attend online but participants must register ahead of time: https://lnkd.in/ghkgvkbE

Neurosom's Chief Operating and Strategy Officer Viral Sheth joined Health Tech Strategies CEO Suzy Engwall for an episode of "Med Tech Minis" to chat about the progress Neurosom has made with Sleep Therapy, our clinical trial, and a hint about AI integration that will be a big story for us in 2025.

As part of a larger conference organized by the Biosignals Technical Committee of Germany. As part of a lecture on biomedical and electrophysiological movement analysis, our Chief Operating and Strategy Officer, Viral Sheth, will give a talk titled Advancing Neurotechnology: Shaping the Future of Sleep and Brain Health with BEL's EEG System One and Sleep WISP, on November 15, 10:30am PT, which will be streamed live from Augsburg, Germany.

Last month, BEL software SOURCERER achieved FDA 510(k) clearance. "FDA clearance of SOURCERER has been a major goal of our team and for the BEL Quality Management System,” said Dr. Don Tucker, CEO and Founder of BEL Company, and of Neurosom. BEL Company was founded in 2017 after a successful sale of a previous company, in order to expand the research and development of neuroscience technology. BEL has continued to develop groundbreaking software and hardware innovations for EEG and the study of the human brain.

Last month, Neurosom was thrilled to be featured on The Unicorn Hunt Podcast. CEO and founder Don Tucker explains the critical mission of improving health through Neurosom Sleep Therapy. Listen as Dr. Tucker dives into the science behind the mechanisms at work during sleep, how Sleep Therapy is able to improve restorative deep sleep, and how AI is being used to accurately classify sleep stages during Sleep Therapy.

Neurosom partner company, BEL receives FDA 510(k) clearance for SOURCERER source estimation software. “SOURCERER is a next generation software that combines an elegant and easy user interface with a faster analysis, precise results, and a managed workflow.

Neurosom’s Sleep WISP Therapy is applied by the user, at home, through a headband worn during sleep. The headband system uses EEG and machine learning to accurately track the user’s sleep cycles. The system applies painless electrical stimulation to facilitate sleep onset as well as extend and enhance deep sleep.

BEL recognizes the SFN conference 2024 and the commitment to excellence in the neuroscience community. Of special interest is the lecture by Dr. Takeshi Iwatsubo on Disease-Modifying Therapies for Alzheimer's Disease. The Sleep WISP device for home sleep improvement is currently in a clinical trial to study Mild Cognitive Impairment funded by the National Institute of Aging.